ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value

$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly asset impairment, restructuring, and other special charges ($M) ($M)

Quarterly figures from Eli Lilly's filings and investor materials

Quarterly Annual

Latest, Q2 2026

703

Period ended Jun 30, 2026

Change on a year earlier

–

0 in Q2 2025

History

68 quarters

Since Q2 2008

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Asset impairment, restructuring, and other special charges ($M) ($M)	Year on year	Source
Q2 2026	Jun 30, 2026	703	–	Form 10-Q (filed 2026-08-05) ↗
Q1 2026	Mar 31, 2026	279	+697.1%	Form 10-Q (filed 2026-04-30) ↗
Q4 2025	Dec 31, 2025	84.1	-75.6%	Form 10-K (filed 2026-02-12) ↗
Q3 2025	Sep 30, 2025	365	+347.2%	Form 10-Q (filed 2025-10-30) ↗
Q2 2025	Jun 30, 2025	0	-100.0%	Form 10-Q (filed 2025-08-07) ↗
Q1 2025	Mar 31, 2025	35	–	Form 10-Q (filed 2025-05-01) ↗
Q4 2024	Dec 31, 2024	344	+406.5%	Form 10-K (filed 2026-02-12) ↗
Q3 2024	Sep 30, 2024	81.6	–	Form 10-Q (filed 2024-10-30) ↗
Q2 2024	Jun 30, 2024	435	–	Form 10-Q (filed 2024-08-08) ↗
Q1 2024	Mar 31, 2024	0	–	Form 10-Q (filed 2025-05-01) ↗
Q4 2023	Dec 31, 2023	68	+78.5%	Form 10-K (filed 2026-02-12) ↗
Q3 2023	Sep 30, 2023	0	-100.0%	Form 10-Q (filed 2023-11-02) ↗
Q2 2023	Jun 30, 2023	0	–	Form 10-Q (filed 2024-08-08) ↗
Q4 2022	Dec 31, 2022	38.1	-63.5%	Form 10-K (filed 2023-02-22) ↗
Q3 2022	Sep 30, 2022	207	–	Form 10-Q (filed 2022-11-01) ↗
Q2 2022	Jun 30, 2022	0	–	Form 10-Q (filed 2022-08-04) ↗
Q1 2022	Mar 31, 2022	0	-100.0%	Form 10-Q (filed 2022-04-29) ↗
Q4 2021	Dec 31, 2021	105	-447.2%	Form 10-K (filed 2022-02-23) ↗
Q3 2021	Sep 30, 2021	0	-100.0%	Form 10-Q (filed 2021-10-27) ↗
Q2 2021	Jun 30, 2021	0	–	Form 10-Q (filed 2021-08-03) ↗
Q1 2021	Mar 31, 2021	212	+253.3%	Form 10-Q (filed 2021-04-30) ↗
Q4 2020	Dec 31, 2020	-30.1	-119.8%	Form 10-K (filed 2021-02-17) ↗
Q3 2020	Sep 30, 2020	101	–	Form 10-Q (filed 2020-10-28) ↗
Q2 2020	Jun 30, 2020	0	–	Form 10-Q (filed 2020-07-31) ↗
Q1 2020	Mar 31, 2020	59.9	-85.9%	Form 10-Q (filed 2020-05-01) ↗
Q4 2019	Dec 31, 2019	152	-21.3%	Form 10-K (filed 2020-02-19) ↗
Q3 2019	Sep 30, 2019	0	-100.0%	Form 10-Q (filed 2019-10-25) ↗
Q2 2019	Jun 30, 2019	0	-100.0%	Form 10-Q (filed 2019-08-02) ↗
Q1 2019	Mar 31, 2019	424	+646.3%	Form 10-Q (filed 2019-05-02) ↗
Q4 2018	Dec 31, 2018	193	-80.8%	Form 10-K (filed 2020-02-19) ↗
Q3 2018	Sep 30, 2018	42.9	-89.4%	Form 10-Q (filed 2019-10-25) ↗
Q2 2018	Jun 30, 2018	-25.5	-151.0%	Form 10-Q (filed 2019-08-02) ↗
Q1 2018	Mar 31, 2018	56.8	-73.4%	Form 10-Q (filed 2019-05-02) ↗
Q4 2017	Dec 31, 2017	1,003	+579.7%	Form 10-K (filed 2018-02-20) ↗
Q3 2017	Sep 30, 2017	407	+793.4%	Form 10-Q (filed 2017-10-27) ↗
Q2 2017	Jun 30, 2017	50	-13.8%	Form 10-Q (filed 2017-07-28) ↗
Q1 2017	Mar 31, 2017	214	+62.8%	Form 10-Q (filed 2017-05-01) ↗
Q4 2016	Dec 31, 2016	148	+1.9%	Form 10-K (filed 2017-02-21) ↗
Q3 2016	Sep 30, 2016	45.5	+7.3%	Form 10-Q (filed 2016-10-28) ↗
Q2 2016	Jun 30, 2016	58	-19.9%	Form 10-Q (filed 2016-07-28) ↗
Q1 2016	Mar 31, 2016	131	+21.7%	Form 10-Q (filed 2016-04-29) ↗
Q4 2015	Dec 31, 2015	145	-63.9%	Form 10-K (filed 2016-02-19) ↗
Q3 2015	Sep 30, 2015	42.4	+16.8%	Form 10-Q (filed 2015-10-30) ↗
Q2 2015	Jun 30, 2015	72.4	–	Form 10-Q (filed 2015-07-30) ↗
Q1 2015	Mar 31, 2015	108	+243.9%	Form 10-Q (filed 2015-04-30) ↗
Q4 2014	Dec 31, 2014	401	–	Form 10-K (filed 2015-02-19) ↗
Q3 2014	Sep 30, 2014	36.3	–	Form 10-Q (filed 2014-10-29) ↗
Q2 2014	Jun 30, 2014	0	-100.0%	Form 10-Q (filed 2014-07-28) ↗
Q1 2014	Mar 31, 2014	31.4	+44.7%	Form 10-Q (filed 2014-04-28) ↗
Q2 2013	Jun 30, 2013	63.5	–	Form 10-Q (filed 2013-07-26) ↗
Q1 2013	Mar 31, 2013	21.7	-8.8%	Form 10-Q (filed 2013-04-26) ↗
Q4 2012	Dec 31, 2012	204	–	Form 10-K (filed 2014-02-19) ↗
Q3 2012	Sep 30, 2012	53.3	-66.2%	Form 10-Q (filed 2012-10-26) ↗
Q2 2012	Jun 30, 2012	0	–	Form 10-Q (filed 2012-07-27) ↗
Q1 2012	Mar 31, 2012	23.8	-68.8%	Form 10-Q (filed 2012-04-30) ↗
Q2 2011	Sep 30, 2011	158	+164.7%	Form 10-Q (filed 2011-10-28) ↗
Q1 2011	Mar 31, 2011	76.3	+191.2%	Form 10-Q (filed 2011-04-29) ↗
Q4 2010	Dec 31, 2010	79	+108.4%	Form 10-K (filed 2011-02-22) ↗
Q3 2010	Sep 30, 2010	59.5	-89.2%	Form 10-Q (filed 2010-10-29) ↗
Q2 2010	Jun 30, 2010	27.3	-74.0%	Form 10-Q/A (filed 2010-08-02) ↗
Q1 2010	Mar 31, 2010	26.2	–	Form 10-Q (filed 2010-04-30) ↗
Q4 2009	Dec 31, 2009	37.9	-52.6%	Form 10-K (filed 2010-02-22) ↗
Q3 2009	Sep 30, 2009	550	-66.9%	Form 10-Q (filed 2009-10-30) ↗
Q2 2009	Jun 30, 2009	105	+18.1%	Form 10-Q (filed 2009-07-31) ↗
Q1 2009	Mar 31, 2009	0	–	Form 10-Q (filed 2010-04-30) ↗
Q4 2008	Dec 31, 2008	80	–	Form 10-K (filed 2010-02-22) ↗
Q3 2008	Sep 30, 2008	1,659	–	Form 10-Q (filed 2009-10-30) ↗
Q2 2008	Jun 30, 2008	88.9	–	Form 10-Q (filed 2009-07-31) ↗

Cite this data

StockData. (2026). Eli Lilly Asset impairment, restructuring, and other special charges ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_restruct

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.